Samsung is recognizing Española Valley High School for its student’s efforts to help people dealing with Parkinson’s Disease.

The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) injection, the first and only ...

A new study published in the Journal of Medical Internet Research has found that regular participation in dance classes can ...

Nicole LaBolle initially dismissed her shaking as something fairly common before facing a Parkinson's diagnosis at 28 ...

Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...

Ozzy Osbourne’s health struggles will not prevent him from taking the stage one final time. Despite being unable to walk, the musician is set to participate in Back to the Beginning — a one-day music ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...

People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...